Literature DB >> 19086166

Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease.

Hans Hildebrand1, Petter Malmborg, Johan Askling, Anders Ekbom, Scott M Montgomery.   

Abstract

OBJECTIVE: An inappropriate immune response to normal bowel flora is implicated in the etiology of Crohn's disease. Tolerance to bowel flora develops in infancy, so factors disrupting normal patterns of bowel colonization may increase the risk of Crohn's disease. The aim of this study was to test the hypothesis that antibiotic therapy between birth and age 5 years may disrupt the pattern of bowel colonization and increase the risk of Crohn's disease.
MATERIAL AND METHODS: Some 1098 patients with Crohn's disease and 6550 controls matched by delivery unit, year of birth, sex, and born between 1973 and 1997 were identified through the Swedish population registers. Seven inpatient diagnoses between birth and age 5 years associated with antibiotic therapy were identified by prospectively recorded data.
RESULTS: Of the seven diagnoses, only pneumonia and otitis media were sufficiently common for use in the analyses. Pneumonia and otitis media were not independent of each other in their association with Crohn's disease and the more important association was with pneumonia. Pneumonia by age 5 years was statistically significantly associated with both pediatric- and adult Crohn's disease, with odds ratios (and 95% CI) of 2.74 (1.04-7.21) and 4.94 (1.83-13.23), respectively. Pneumonia after age 5 years was not statistically significantly associated with Crohn's disease.
CONCLUSIONS: Pneumonia prior to age 5 years, but not later, was associated with subsequent Crohn's disease and this may represent either susceptibility or causation. The results are consistent with early exposures influencing immune function, such as through disruption of bowel colonization, and thus increasing the risk of Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19086166     DOI: 10.1080/00365520801971736

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  38 in total

Review 1.  The epidemiology and risk factors of inflammatory bowel disease.

Authors:  Yulan Ye; Zhi Pang; Weichang Chen; Songwen Ju; Chunli Zhou
Journal:  Int J Clin Exp Med       Date:  2015-12-15

2.  Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.

Authors:  Seth D Crockett; Carol Q Porter; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

3.  High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease.

Authors:  Jee-Yon Lee; Stephanie A Cevallos; Mariana X Byndloss; Connor R Tiffany; Erin E Olsan; Brian P Butler; Briana M Young; Andrew W L Rogers; Henry Nguyen; Kyongchol Kim; Sang-Woon Choi; Eunsoo Bae; Je Hee Lee; Ui-Gi Min; Duk-Chul Lee; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2020-07-14       Impact factor: 21.023

4.  Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn's Disease.

Authors:  James R Irwin; Emma Ferguson; Lisa A Simms; Katherine Hanigan; James D Doecke; Daman Langguth; Ashley Arnott; Graham Radford-Smith
Journal:  Dig Dis Sci       Date:  2018-11-26       Impact factor: 3.199

5.  Multicenter case-control study of the risk factors for ulcerative colitis in China.

Authors:  Yu-Fang Wang; Qin Ou-Yang; Bing Xia; Li-Na Liu; Fang Gu; Kai-Fang Zhou; Qiao Mei; Rui-Hua Shi; Zhi-Hua Ran; Xiao-Di Wang; Pin-Jin Hu; Kai-Chun Wu; Xin-Guang Liu; Ying-Lei Miao; Ying Han; Xiao-Ping Wu; Guo-Bing He; Jie Zhong; Guan-Jian Liu
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

6.  Crohn's disease as an immunodeficiency.

Authors:  Bu'Hussain Hayee; Farooq Z Rahman; Gavin Sewell; Andrew M Smith; Anthony W Segal
Journal:  Expert Rev Clin Immunol       Date:  2010-07       Impact factor: 4.473

7.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

Review 8.  Epidemiological studies of migration and environmental risk factors in the inflammatory bowel diseases.

Authors:  Yanna Ko; Rhys Butcher; Rupert W Leong
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 9.  Environmental risk factors for inflammatory bowel diseases: Evidence based literature review.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Owais Bhatti; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

10.  Antibiotic exposure and IBD development among children: a population-based cohort study.

Authors:  Matthew P Kronman; Theoklis E Zaoutis; Kevin Haynes; Rui Feng; Susan E Coffin
Journal:  Pediatrics       Date:  2012-09-24       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.